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Abstract: Encapsulation of a biological molecule or a molecular complex in a vesicle provides a means of
biofriendly immobilization for single molecule studies and further enables new types of analysis if the vesicles
are permeable. We previously reported on using DMPC (dimyristoylphosphatidylcholine) vesicles for realizing
porous bioreactors. Here, we describe a different strategy for making porous vesicles using a bacterial
pore-forming toxin, R-hemolysin. Using RNA folding as a test case, we demonstrate that protein-based
pores can allow exchange of magnesium ions through the vesicle wall while keeping the RNA molecule
inside. Flow measurements indicate that the encapsulated RNA molecules rapidly respond to the change
in the outside buffer condition. The approach was further tested by coencapsulating a helicase protein and
its single-stranded DNA track. The DNA translocation activity of E. coli Rep helicase inside vesicles was
fueled by ATP provided outside the vesicle, and a dramatically higher number of translocation cycles could
be observed due to the minuscule vesicle volume that facilitates rapid rebinding after dissociation. These
pores are known to be stable over a wide range of experimental conditions, especially at various
temperatures, which is not possible with the previous method using DMPC vesicles. Moreover, engineered
mutants of the utilized toxin can potentially be exploited in the future applications.
Introduction
Single molecule ﬂuorescence techniques are revolutionizing
biological inquiries both in vitro and in vivo.
1-4 In order to
observe single molecule reactions for an extended period,
molecular movements via diffusion have to be slower than the
time scale of the method used to track their movements.
Although it is possible to track particles in one dimension, for
example cytoskeleton motor proteins moving on actin ﬁlaments
5
or microtubules,
6 or in two dimensions, as in the case of
membrane protein diffusion,
7 there are many other examples
where three-dimensional diffusion would preclude an extended
observation time window. Therefore, several methodologies
have been developed to keep the molecules of interest under
observation for prolonged periods. Immobilization via biotin-
streptavidin anchors on bare
8 or polymer-grafted surfaces
9 and
conﬁnement within agarose or polyacrylamide gels
10 are very
useful strategies, yet care should be taken to ensure minimal
perturbation to the activity of biological molecules. A recent
report
11 described an elegant technology for the conﬁnement
of individual molecules in free solution by means of anti-
Brownian electrokinetic trapping (ABEL). ABEL, however, does
not allow changing the solution condition while keeping the
molecule trapped. An alternative approach entraps a molecule
within a small unilamellar vesicle (SUV) which is then tethered
on surfaces.
12-14 Vesicle encapsulation has been used to study
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15 RNA folding,
12 DNA folding,
8 DNA-protein
interaction,
16 protein-protein interaction,
14 and protein con-
formational changes.
17 In principle, vesicle encapsulation should
provide a more biofriendly environment,
18 which may help avoid
artifacts sometimes caused by direct surface tethering of
proteins,
17,19 because the immediate environment is composed
of lipid molecules rather than an artiﬁcial solid substrate such
as a glass slide. Vesicle encapsulation also obviates the need to
modify biological molecules for surface tethering (e.g., bioti-
nylation), offering ease and ﬂexibility to the researchers as was
utilized to determine the effect on FRET of dipole orientations
of the ﬂuorophores stacked at DNA duplex ends.
20 However,
the inability to exchange buffer across the vesicle wall was noted
as the major drawback
9 because buffer exchange is commonly
practiced either for examining molecules under various condi-
tions, for example by varying concentration of certain chemical
agents between measurements,
8 or for triggering certain reac-
tions on demand.
21 Rendering the vesicles porous is therefore
essential for fully realizing the potential of the encapsulation
approach. This is already achieved for bulk assays,
22-24 but their
adaptation for single molecule experiments has been limited.
Porous vesicles should also be useful if the measurement
condition is not suitable for vesicle formation. In such circum-
stances, vesicles can be formed under conditions favorable for
encapsulation, and the solution condition can then be changed
to the desired imaging conditions. Furthermore, because porous
vesicles allow buffer exchange without washing out the
encapsulated molecules, it would be possible to monitor the
interaction between the same pair of biomolecules under various
conditions. Finally, the presence of pores prevents the vesicle-
to-vesicle variation of intravesicular conditions, for example ion
concentrations, emerging from stochastic encapsulation and
vesicle size distribution (further discussed in Supporting Infor-
mation), which may be important for studying systems that
display strong heterogeneity.
12 In this regard, pores ensure that
the intravesicular condition is in equilibrium with the bulk
solution, hence remains identical between vesicles. Clearly,
introducing pores on vesicles should greatly expand the venues
for single molecule vesicle encapsulation assays.
In order to fully harness the capabilities of vesicle encapsula-
tion and overcome the impermeability barrier, we recently
exploited the thermotropic properties of lipid membranes
16
where the membrane permeability of solutes reaches a maximum
around membrane’s melting temperature (Tm). We showed
previously that the vesicles made of the phospholipids DMPC
(dimyristoylphosphatidylcholine) (Tm ) 23 °C) can readily allow
the passage of K+ 12 and ATP and its analogues
16 at room
temperature. Nevertheless, the pores rely on transient formation
of lipid packing defects, and their presence and properties may
be affected by many factors. An obvious limitation is that the
working temperature range is narrow with the membrane being
porous only within 3 °Co fTm,
25 making it laborious to carry
out measurements at various temperatures. For steady-state
measurements, one would need to incubate the sample with the
desired buffer at the Tm of the lipid membrane before taking
data at a new temperature. Moreover, data acquisition at
temperatures different from Tm would be problematic if the
encapsulated reaction consumes substrates (e.g., ATP), as their
consumption and product accumulation will alter the dynamics.
Finally, nonequilibrium kinetic experiments, for example via
ﬂow, at various temperatures would require several different
lipid compositions with Tm values that match those of the
temperatures to be used. We therefore utilized a bacterial toxin,
R-hemolysin (aHL), to induce stable pores on SUVs, which had
been previously used for bulk measurements in an attempt to
build an artiﬁcial cell.
22 We proposed using aHL in an earlier
report,
16 and the actual implementation is the subject of this
article.
aHL is a bacterial toxin secreted by Staphylococcus aureus
as water-soluble monomers which incorporate into lipid mem-
branes to form a heptametric pore.
26 There are several reasons
for our choice of aHL: (i) Owing to spontaneous incorporation
of aHL into the membrane, such pores are easier to make than
many other membrane proteins which require difﬁcult recon-
stitution procedures. (ii) Once formed, aHL pores are stable in
a wide variety of buffer conditions, pH, and temperature. (iii)
The aHL pore with a narrowest opening of 1.8 nm is not
selective, allowing passive passage of molecules up to 3kD both
ways.
27 (iv) Finally, available engineered mutants of aHL may
be further utilized to achieve unique experimental assays.
Here, we carried out the proof-of-concept experiments using
smFRET (single molecule ﬂuorescence resonance energy
transfer)
28,29 on a home-built total internal reﬂection ﬂuorescence
setup (Figure 1) using three different model systems. First, the
hairpin ribozyme whose single molecule behavior under various
conditions is well-characterized
30 served as a molecular reporter
for the intravesicular buffer condition, in this case magnesium
ion concentration. Second, the RNA four-way junction was also
used as a well-characterized test system.
31 As the third model
system we encapsulated E. coli Rep helicase together with its
DNA substrate in order to demonstrate the passage of ATP
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protein-DNA interactions for a prolonged period.
Materials and Methods
FRET Measurements. All experiments were carried out using
a prism-based two-color total internal reﬂection ﬂuorescence
microscope capable of single molecule FRET analysis
28 at room
temperature and with 100 ms exposure time unless otherwise stated.
A 532 nm laser was used for donor excitation in FRET measure-
ments. A 633 nm laser was used to excite the acceptor directly to
conﬁrm colocalization of a donor-labeled Rep helicase and an
acceptor-labeled DNA. FRET efﬁciency was calculated as the
acceptor intensity divided by the total intensity of donor and
acceptor ﬂuorescence averaged over 1 s. Data from hundreds of
molecules were pooled to obtain FRET histograms. Noise in the
measurements could yield FRET values below 0 and above 1 due
to negative values after background subtraction for the acceptor
and donor intensities, respectively. The leftmost peak in FRET
histograms represents donor only population, hence was ignored
in data interpretation.
Ribozyme Encapsulation. The encapsulation of the hairpin
ribozyme in vesicles, immobilization of SUV on a supported lipid
bilayer, RNaseA and nonspeciﬁc immobilization controls, imaging,
data acquisition, and data analysis were performed as described
previously.
12 SUVs encapsulating the ribozyme were formed in a
0.5 mM Mg2+ RNA buffer (10 mM Tris-HCl pH 7.4, 50 mM NaCl,
0.4% (w/w) glucose, and speciﬁed amounts of MgCl2) and were
then incubated with the surface for speciﬁc attachment. The hairpin
ribozyme molecules used in these studies did not contain a biotin
moiety, thus removal of unencapsulated RNA via gel ﬁltration prior
to vesicle tethering was not needed. RNA concentrations during
encapsulation were chosen to minimize the probability of encap-
sulating multiple molecules. Lipid ﬁlms for the encapsulation were
made of EggPC with 1% DPPE-biotin.
Puriﬁcation and Characterization of aHL. Our initial attempts
with the commercial aHL (Calbiochem) were not successful in
forming pores despite our efforts that explored a wide variety of
experimental conditions. As this failure is likely due to the low
concentration of commercially available aHL (the practical maxi-
mum concentration we could use was ∼1 µM in monomer), we
produced aHL in-house. We overexpressed hexahistidine-tagged
aHL from a plasmid in Escherichia coli and puriﬁed the protein
using a Ni-NTA column, and the protein activity was conﬁrmed
by the hemolysis assay (Supporting Information Figure 2). Recom-
binant aHL concentration was estimated to be ∼36 µMb y
quantitative Western blotting. For long-term storage, aHL was
divided into aliquots, ﬂash frozen, and kept at -80 °C.
aHL Incorporation on SUV. RNA-encapsulating SUVs were
diluted (200-500 pM ﬁnal SUV concentration) in buffer A (10
mM Tris pH 8.0, 200 mM NaCl, 0.1 mg/mL BSA) containing high
concentrations (∼36 µM monomer) of puriﬁed recombinant aHL.
Incubation was carried out at 37 °C for at least 30 min. Various
lower concentrations of aHL resulted in the poration of various
fractions of SUVs, but 36 µM yielded reproducible results with
nearly 100% yield of pore formation as judged by the fraction of
molecules that fold when the extravesicular buffer was exchanged
from no Mg2+ t o1o r1 0m MM g 2+ condition. Pore formation does
not happen when vesicles were incubated with aHL subsequent to
immobilization, most likely because most of the aHL was captured
by the supported lipid bilayer.
Rep Helicase Encapsulation. Partial duplex DNA (400 nM,
double-stranded DNA of 18 base pairs with a 3′ (dT)80 and a Cy5
attached to the junction) and a 400 nM concentration of Rep
molecules
32 labeled with a donor ﬂuorophore (Cy3) mixed in a
total volume of 200 µL of buffer R (20 mM Tris pH 8.0, 500 mM
NaCl) were used to hydrate 2.5 mg of lipid ﬁlms. In order to
achieve, on the average, one molecule of each kind (i.e., one protein
vs one DNA) in a 100 nm diameter vesicle, a concentration of 400
nM was chosen. Buffer R contains 500 mM to ensure that the
labeled Rep does not aggregate, as when high concentrations of
dye-labeled Rep monomers are dissolved under low salt conditions.
(32) Myong, S.; Rasnik, I.; Joo, C.; Lohman, T. M.; Ha, T. Nature 2005,
437, 1321–5.
Figure 1. A diagram summarizing the experimental scheme (not to scale). (Left) A home-built prism-type total internal reﬂection microscope with two-
color ﬂuorescence detection. (Right) The encapsulation assay. A supported lipid bilayer (a single membrane layer is depicted as one gray stripe) is ﬁrst
formed on a quartz coverslide (yellow) as a cushion. SUVs are then immobilized on the lipid cushion through biotin (brown dots)-streptavidin or neutravidin
(blue) linker. The aHL pores on the SUV are shown also in blue. Encapsulated inside SUVs is the biomolecule (orange), depicted in folded and unfolded
conformations at two and eight o’clock positions, respectively. The molecule is labeled with a donor (green) and an acceptor (red) which serve as FRET
probes. The star shape represents the brighter ﬂuorophore. Black circles represent the chemical agent (e.g., Mg2+ or ATP) relevant to the reaction under
study.
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trations were scaled accordingly) diameter vesicles were formed
via extrusion. Skipping the freeze-thaw cycles was found to be
essential in keeping the proteins active (Supporting Information).
Finally, unencapsulated Rep molecules were separated from the
vesicles by a Ni-NTA column via the histidine tag on the protein.
While buffer R had to be used during encapsulation to avoid
clumping of Rep, it had to be exchanged with the imaging buffer
4
(10 mM Tris-HCl, pH 7.6, 1 mM ATP, 12 mM MgCl2,1 5m M
NaCl, 10% (v/v) glycerol, 0.4% (w/w) glucose, anti-blinking agents
such as 2-mercaptoethanol or Trolox, and oxygen scavenging
system utilizing catalase and glucose oxidase) during data acquisi-
tion because high salt concentration in buffer R does not allow
Rep to bind to the DNA. Further details on Rep helicase encapsula-
tion can be found in Supporting Information.
Results and Discussion
Hairpin Ribozyme Experiments. In the presence of high (g1
mM) Mg2+ concentrations, the ribozyme folds into a compact
structure (Figure 2, right panel) bringing the two arms carrying
the donor (Cy3) and the acceptor (Cy5) closer and displays high
FRET efﬁciency (∼0.8). The ribozyme is unfolded in the
absence of Mg2+ ions and shows low FRET (∼0.2). At the
intermediate Mg2+ concentration (0.5 mM), ribozyme spontane-
ously ﬂuctuates between folded and unfolded conformations,
and the FRET signal switches between the low and high values,
resulting in two distinct peaks in the FRET histogram.
EggPC vesicles encapsulating the hairpin ribozyme construct
were immobilized to the supported lipid bilayer
33 formed on a
quartz slide via biotin-streptavidin interaction.
12 For all
measurements, nonspeciﬁc binding of RNA and the SUVs to
the surface was negligible. The ﬂuorescence spots did not
disappear after treating the surface with RNaseA, demonstrating
that the RNA molecules are protected from digestion through
encapsulation.
12 FRET histograms of the encapsulated molecules
for all tested conditions (0, 0.5, 1, and 10 mM Mg2+) were
indistinguishable from that of the Mg2+ concentration used
during encapsulation (0.5 mM) (Figure 2, top left panel),
demonstrating a successful encapsulation that yields a well-
deﬁned and isolated intravesicular environment.
12
In contrast, upon treating the vesicles with aHL (Materials
and Methods), the encapsulated RNA molecules changed their
FRET histograms in response to the changes in the outside
buffer condition (Figure 2, middle and bottom left panels). In
the absence of Mg2+, RNA molecules were almost completely
unfolded (low FRET population only). Under 0.5 mM Mg2+,
RNA molecules displayed spontaneous switching between
folded and unfolded conformations (coexistence of low and high
FRET). At 1 mM or 10 mM Mg2+, RNA molecules were almost
completely folded (high FRET only). All conditions were tested
multiple times in different sequences, and buffer exchange was
fully reversible. We conclude that the aHL pore formation works
reliably and allows us to change the intravesicular salt concen-
tration in a reversible fashion, keeping the RNA encapsulated.
Flow Measurements. We used a ﬂow delivery system to test
how fast the buffer exchange through the pores takes place. We
changed the solution condition (from no Mg2+ to 0.5 mM, 1
mM, or 10 mM Mg2+) typically 5-6 s after starting the data
acquisition. The initial low FRET signal in the absence of Mg2+
rapidly increased upon ﬂow of Mg2+. Although the ﬂow data
is shown only for 10 mM Mg2+ (Figure 3a), all conditions gave
qualitatively similar behavior. Folding happened within the ﬁrst
few seconds for the majority of molecules: Only ∼10% of the
molecules remained unfolded 3 s after injection of Mg2+ (Figure
3b). We therefore conclude that the number of pores per SUV
was high enough (Supporting Information) for changing the
buffer condition on a time scale relevant for the hairpin ribozyme
folding which typically requires about1st ofold at Mg2+
concentrations above 0.5 mM.
30,34
RNA Four-Way Junction Experiments. The RNA four-way
junction, which is derived from the hairpin ribozyme by fully
basepairing the loop structures, rapidly ﬂuctuates between
multiple conformations in the presence of Mg2+. Such ﬂuctua-
tions become slow enough to be measured within our time
resolution at room temperature only at high concentrations of
Mg2+ (g50 mM).
30 Previously, we tried to encapsulate the
junction in SUVs in order to ensure that the measurements were
(33) Chan, Y. H.; Boxer, S. G. Curr. Opin. Chem. Biol. 2007, 11, 581–7.
(34) Zhuang, X.; Kim, H.; Pereira, M. J.; Babcock, H. P.; Walter, N. G.;
Chu, S. Science 2002, 296, 1473–6.
Figure 2. (Right) A cartoon summarizing the hairpin ribozyme behavior,
where the ribozyme is shown in unfolded (top) and folded (bottom)
conformations. Donor and acceptor dyes are depicted in light and dark gray,
respectively. (Left) FRET efﬁciency histograms of single encapsulated
hairpin ribozymes. Mg2+ concentrations in the imaging buffer are displayed
on each histogram. Not all of the assayed concentrations are shown. (Top)
Ribozyme encapsulated in 0.5 mM Mg2+, measured with no Mg2+ outside
SUV in the absence of aHL. Regardless of the outside imaging conditions,
encapsulated ribozyme exhibited spontaneous ﬂuctuations between folded
and unfolded states,
12 which is a typical behavior for 0.5 mM Mg2+. The
resultant histogram is hence a superposition of Gaussian distributions peaked
around high and low FRET values, in addition to a peak at zero FRET due
to the donor-only species. (Middle) Ribozyme encapsulated in 0.5 mM
Mg2+, measured with no Mg2+ outside with aHL incorporated. Ribozyme
remains stably unfolded. (Bottom) Ribozyme encapsulated in 0.5 mM Mg2+,
measured with 0.5 mM Mg2+ subsequent to the measurement described in
the middle panel. Ribozyme responds to the change in the outside buffer
conditions thanks to the pores.
J. AM. CHEM. SOC. 9 VOL. 131, NO. 41, 2009 14847
Porous Single Molecule Nanocontainers ARTICLESnot altered by the interactions with the surface.
12 However, all
of our attempts to encapsulate the junction at 50 mM Mg2+
failed because SUVs did not form at such high Mg2+ concentra-
tions. Having developed the aHL approach, we tackled this
problem once more where junction-encapsulating SUVs were
ﬁrst prepared in the absence of Mg2+. Subsequently, pores were
formed using aHL, and imaging was carried out in the buffer
containing 50 mM Mg2+. The dynamic behavior previously
Figure 3. (a) At t ) 0, ribozymes encapsulated in porous SUVs are subject to no Mg2+, hence stay unfolded (low FRET). Upon injection of 10 mM Mg2+
into the sample chamber (between ﬁfth and sixth seconds after data acquisition, marked with a dashed arrow), ribozymes rapidly fold (transition to high
FRET). The duration for the FRET value to reach ∼0.8 from t ) 0 is deﬁned as time of folding (tfolding). The top and the bottom graphs belong to different
SUVs (hence different ribozymes) from the same run (thin, black line: raw data; thick, gray line: B-spline smoothed data). (b) Histogram for times of folding
(top) and corresponding percentile cumulative folding probability vs time (bottom) obtained from individual traces.
Figure 4. (a) Rep helicase labeled with donor, and DNA labeled with acceptor at the junction depicted as coencapsulated within a porous SUV. Partial
duplex DNA is an 18bp double strand carrying a (dT)80 tail. (b) Rep shuttling data obtained from surface-tethered DNA (modiﬁed from ref 32) with a same
length tail. Inset shows a single translocation event where the gradual increase in the acceptor signal (with accompanying decrease in the donor signal)
reﬂects translocation of Rep toward the junction, whereas the abrupt drop marks the snapping back to the 3′ end. The translocation time (∆t) is deﬁned as
the period between consecutive snapping events. Individual cycles of shuttling separated in time are due to different Rep molecules from solution binding
on the same surface-attached DNA and exhibiting limited repetitive translocations until dissociation. (c) FRET trace of Rep shuttling on a (dT)80 DNA
within 100 nm diameter porous SUVs. In marked contrast to the surface experiments, a single Rep-DNA pair shows over 140 translocation events until
acceptor photobleaching near 130 s). Time resolution was 30 ms. (d) ∆t histograms can be built from a single Rep-DNA pair. Similar statistics for surface
measurements (b) can only be obtained by merging data from translocations events from many shuttling cycles exhibited by different Rep molecules.
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duced
30 (Supporting Information Figure 1). aHL can therefore
be utilized in such cases for which the measurement conditions
are not suitable for the formation of SUV.
Rep Helicase Experiments. Next, we encapsulated an acceptor
(Cy5)-labeled partial duplex DNA with a donor (Cy3)-labeled
Rep helicase monomer in SUVs (Materials and Methods and
Figure 4a) in order to conﬁrm the ATP passage through aHL
pores. A Rep monomer, which cannot unwind duplex DNA by
itself,
21,35 can translocate on a single-stranded DNA in the 3′
to 5′ direction. When Rep encounters a blockade (such as a
double-stranded DNA) on its track, it snaps back to the 3′ end
on its substrate. These repetitive translocation events (termed
shuttling) continue until the Rep monomer dissociates from
DNA.
32 Such measurements were previously carried out on
DNA molecules tethered to a quartz surface coated with
polymers. For the surface experiments, shuttling takes place a
limited number of times (typically less than 10) due to eventual
dissociation, and the number of translocation events is thus
inadequate for inferring statistically signiﬁcant information on
the shuttling properties from a single Rep helicase (Figure 4b).
In contrast, we expected that encapsulation would enable long-
term monitoring of shuttling for a single pair of Rep and DNA,
as the molecules would quickly rebind within the minuscule
SUV volume.
Upon surface immobilization of SUVs, and subsequent ATP
injection, shuttling events were observed within SUVs (Figure
4c), indicating the ATP passage through aHL. The translocation
activity was observed only when aHL was incorporated and
ATP was present. Number of repetitive translocation events that
can be observed from an individual Rep was substantially higher
in the SUVs compared to the surface assays as anticipated. When
encapsulated, a single Rep-DNA pair exhibited shuttling
essentially until photobleaching of the ﬂuorophores. Such
enhancement for the number of shuttling events makes it
possible to observe more than 100 cycles of translocation from
an individual Rep-DNA pair and to obtain the kinetic param-
eters reliably free of complications arising from single molecule
heterogeneity (Figure 4d).
In conclusion, in order to fully harness the capabilities of
the vesicle encapsulation, we described here a generalizable
methodology for making robustly porous vesicles. aHL pores
utilized in this study allowed rapid passage of Mg2+ as well as
ATP through membranes of phospholipids SUVs. Compared
to the thermothropically rendered defects, aHL pores are well-
deﬁned and stable at various temperatures. In the future,
engineered aHL mutants of which opening/closing can be
controlled via different chemical or optical means
27,36,37 may
be exploited to design novel experimental platforms.
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